Endocrinology, Vol 136, 2377-2382, Copyright © 1995 by Endocrine Society

ARTICLES

Expression of a novel receptor for the calcitonin peptide family and a salmon calcitonin-like peptide in the alpha-thyrotropin thyrotroph cell line

FW Hanna, DM Smith, CF Johnston, KO Akinsanya, ML Jackson, DG Morgan, R Bhogal, KD Buchanan and SR Bloom
Department of Medicine, Wellcome Research Laboratories, Queen's University of Belfast, United Kingdom.

We have previously shown an increased incidence of alpha-subunit- producing thyrotroph tumors after salmon calcitonin (sCT) injection into rats. However, it is not clear whether the effects of CT are direct or indirect. Our hypothesis was that for sCT to act directly, it must have a binding site on thyrotrophs. The alpha TSH cell line was used as a model for thyrotrophs. Receptor binding studies using alpha TSH membranes revealed a high affinity binding site for sCT [IC50 = 0.97 +/- 0.18 nM (n = 4); Kd = 5.45 +/- 0.43 nM (n = 3); binding capacity = 6.6 pmol/mg protein (n = 3)]. Rat CT did not compete with binding at this site. Receptor screening for other CT peptide family members revealed high specific binding for CT gene-related peptide (CGRP; IC50 = 0.25 +/- 0.08 nM; n = 3) and islet amyloid polypeptide (IC50 = 4.36 +/- 1.1 nM; n = 3). This together with the absence of rat CT binding excluded a conventional CT-binding site, and we propose a site similar to the CGRP subtype III receptor described in the rat nucleus accumbens. Guanosine 5'O-(3-thiotriphosphate) (GTP gamma S) (20 microM), reduced [125I]CGRP binding to 38% of maximal, indicating that this site is G-protein coupled. Immunocytochemically, all of the cells displayed intense sCT-like immunoreactivity, which was totally abolished by preabsorption of the antibody with sCT. The presence of this receptor supports the hypothesis that sCT mediates tumorigenesis via a direct pituitary action and, together with the coexistence of a sCT-like peptide in these cells, provides evidence for a possible autocrine role of this peptide in the control of thyrotroph function.

This article has been cited by other articles:

				G. Christopoulos, K. J. Perry, M. Morfis, N. Tilakaratne, Y. Gao, N. J. Fraser, M. J. Main, S. M. Foord, and P. M. Sexton Multiple Amylin Receptors Arise from Receptor Activity-Modifying Protein Interaction with the Calcitonin Receptor Gene Product Mol. Pharmacol., July 1, 1999; 56(1): 235 - 242. [Abstract] [Full Text]

				J. M. Hilton, K. I. Mitchelhill, G. Pozvek, M. Dowton, M. Quiza, and P. M. Sexton Purification of Calcitonin-Like Peptides from Rat Brain and Pituitary Endocrinology, March 1, 1998; 139(3): 982 - 992. [Abstract] [Full Text] [PDF]

				K. J. Perry, M. Quiza, D. E. Myers, M. Morfis, G. Christopoulos, and P. M. Sexton Characterization of Amylin and Calcitonin Receptor Binding in the Mouse {alpha}-Thyroid-Stimulating Hormone Thyrotroph Cell Line Endocrinology, August 1, 1997; 138(8): 3486 - 3496. [Abstract] [Full Text] [PDF]

				L. J. Deftos, MD Editorial: There's Something Fishy and Perhaps Even Fowl about the Mammalian Calcitonin Receptor and Its Ligand Endocrinology, February 1, 1997; 138(2): 519 - 520. [Full Text] [PDF]